✦ LIBER ✦

Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane

✍ Scribed by Ulana Kotowski; Gregor Heiduschka; Markus Brunner; Cornelia Czembirek; Christina Eder-Czembirek; Rainer Schmidt; Tammer Fahim; Dietmar Thurnher

Book ID: 105776931
Publisher: Springer
Year: 2011
Tongue: German
Weight: 372 KB
Volume: 187
Category: Article
ISSN: 0179-7158
DOI: 10.1007/s00066-011-2218-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiosensitivity of head and neck cancer

Radiosensitivity of head and neck cancer cells in vitro

✍ Westlund, K.J. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 151 KB

P65 Radiosensitization by histone deacet

P65 Radiosensitization by histone deacetylase inhibitors +/− demethylating agents in head and neck cancer cell lines

✍ H. De Schutter; W. Van Criekinge; S. Nuyts 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Radiosensitization by an anti-EGFR singl

Radiosensitization by an anti-EGFR single chain antibody in human head and neck cancer cells

✍ J. Bonner; H.Q. Trummell; L.L. Sanford; K.P. Raisch 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 228 KB

The Role of STAT-3 in Cetuximab-induced

The Role of STAT-3 in Cetuximab-induced Radiosensitization in Head-and-Neck Cancer Cells

✍ Bonner, J.A.; Trummell, H.; Nowsheen, S.; Yang, E.S. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Radiosensitivity and effect of hypoxia i

Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells

✍ Sørensen, Brita Singers; Busk, Morten; Olthof, Nadine; Speel, Ernst-Jan; Horsman 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 655 KB

Sirolimus as a potential radiosensitizer

Sirolimus as a potential radiosensitizer in squamous cell cancer of the head and neck

✍ Eric T. Shinohara; Amit Maity; Neha Jha; Robert A. Lustig 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

## Abstract ## Background. An estimated 34,000 cases of squamous cell carcinomas of the head and neck (HNSCC) will be diagnosed in 2007 with 7500 estimated deaths. Radiation is commonly used to treat these patients. Preclinical studies have suggested that sirolimus may be an effective radiosensiti